Reference (R)
Sponsors
Boehringer Ingelheim, The Affiliated Hospital of Qingdao University
Conditions
HealthyOsteoporosis
Phase 1
A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food
CompletedNCT05428436
Start: 2022-08-15End: 2022-09-30Updated: 2025-12-19
A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects
Not yet recruitingNCT06753864
Start: 2025-01-02End: 2025-05-01Target: 32Updated: 2024-12-31